Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 331

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

Open access
Burnichon, Nelly, Cascón, Alberto, Schiavi, Francesca, Morales, Nicole Paes, Comino-Méndez, Iñaki, Abermil, Nasséra, Inglada-Pérez, Lucía, de Cubas, Aguirre A., Amar, Laurence, Barontini, Marta, de Quirós, Sandra Bernaldo, Bertherat, Jérôme, Bignon, Yves-Jean, Blok, Marinus J., Bobisse, Sara, Borrego, Salud, Castellano, Maurizio, Chanson, Philippe, Chiara, María-Dolores, Corssmit, Eleonora P.M., Giacchè, Mara, de Krijger, Ronald R., Ercolino, Tonino, Girerd, Xavier, Gómez-García, Encarna B., Gómez-Graña, Álvaro, Guilhem, Isabelle, Hes, Frederik J., Honrado, Emiliano, Korpershoek, Esther, Lenders, Jacques W.M., Letón, Rocío, Mensenkamp, Arjen R., Merlo, Anna, Mori, Luigi, Murat, Arnaud, Pierre, Peggy, Plouin, Pierre-François, Prodanov, Tamara, Quesada-Charneco, Miguel, Qin, Nan, Rapizzi, Elena, Raymond, Victoria, Reisch, Nicole, Roncador, Giovanna, Ruiz-Ferrer, Macarena, Schillo, Frank, Stegmann, Alexander P.A., Suarez, Carlos, Taschin, Elisa, Timmers, Henri J.L.M., Tops, Carli M.J., Urioste, Miguel, Beuschlein, Felix, Pacak, Karel, Mannelli, Massimo, Dahia, Patricia L. M., Opocher, Giuseppe, Eisenhofer, Graeme, Gimenez-Roqueplo, Anne-Paule, Robledo, Mercedes · 2012 · Clinical Cancer Research

Abstract

Purpose: Pheochromocytomas (PCC) and paragangliomas (PGL) are genetically heterogeneous neural crest–derived neoplasms. Recently we identified germline mutations in a new tumor suppressor susceptibility gene, MAX (MYC-associated factor X), which predisposes carriers to PCC. How MAX mutations contribute to PCC/PGL and associated phenotypes remain unclear. This study aimed to examine the prevalence and associated phenotypic features of germline and somatic MAX mutations in PCC/PGL. Design: We sequenced MAX in 1,694 patients with PCC or PGL (without mutations in other major susceptibility genes) from 17 independent referral centers. We screened for large deletions/duplications in 1,535 patients using a multiplex PCR-based method. Somatic mutations were searched for in tumors from an additional 245 patients. The frequency and type of MAX mutation was assessed overall and by clinical characteristics. Results: Sixteen MAX pathogenic mutations were identified in 23 index patients. All had adrenal tumors, including 13 bilateral or multiple PCCs within the same gland (P < 0.001), 15.8% developed additional tumors at thoracoabdominal sites, and 37% had familial antecedents. Age at diagnosis was lower (P = 0.001) in MAX mutation carriers compared with nonmutated cases. Two patients (10.5%) developed metastatic disease. A mutation affecting MAX was found in five tumors, four of them confirmed as somatic (1.65%). MAX tumors were characterized by substantial increases in normetanephrine, associated with normal or minor increases in metanephrine. Conclusions: Germline mutations in MAX are responsible for 1.12% of PCC/PGL in patients without evidence of other known mutations and should be considered in the genetic work-up of these patients. Clin Cancer Res; 18(10); 2828–37. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-12-0160

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 331

Metadata

Authors
Burnichon, N., Cascón, A., Schiavi, F., Morales, N. P., Comino-Méndez, I., Abermil, N., Inglada-Pérez, L., de Cubas, A. A., Amar, L., Barontini, M., de Quirós, S. B., Bertherat, J., Bignon, Y.-J., Blok, M. J., Bobisse, S., Borrego, S., Castellano, M., Chanson, P., Chiara, M.-D., Corssmit, E. P. M., Giacchè, M., de Krijger, R. R., Ercolino, T., Girerd, X., Gómez-García, E. B., Gómez-Graña, Á., Guilhem, I., Hes, F. J., Honrado, E., Korpershoek, E., Lenders, J. W. M., Letón, R., Mensenkamp, A. R., Merlo, A., Mori, L., Murat, A., Pierre, P., Plouin, P.-F., Prodanov, T., Quesada-Charneco, M., Qin, N., Rapizzi, E., Raymond, V., Reisch, N., Roncador, G., Ruiz-Ferrer, M., Schillo, F., Stegmann, A. P. A., Suarez, C., Taschin, E., Timmers, H. J. L. M., Tops, C. M. J., Urioste, M., Beuschlein, F., Pacak, K., Mannelli, M., Dahia, P. L. M., Opocher, G., Eisenhofer, G., Gimenez-Roqueplo, A.-P., & Robledo, M.
Venue
Clinical Cancer Research
Published
2012-05-14
Volume
18
Issue
10
Pages
2828-2837
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2046661986
Cited by
331
References
34
FWCI
29.16
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-12-0160
The paper
Burnichon, N., Cascón, A., Schiavi, F., Morales, N. P., Comino-Méndez, I., Abermil, N., Inglada-Pérez, L., de Cubas, A. A., Amar, L., Barontini, M., de Quirós, S. B., Bertherat, J., Bignon, Y.-J., Blok, M. J., Bobisse, S., Borrego, S., Castellano, M., Chanson, P., Chiara, M.-D., . . . Robledo, M. (2012). MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-12-0160

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.